MediVance | Medical device technologies

Endoskeleton TCS


Interbody Fusion


Titan Spine

The proprietary ENDOSKELETON® interbody devices are designed to promote bony ongrowth, optimize intervertebral stability, allow for increased bone graft material, and permit excellent visualization on postoperative CT and MRI scans.


Proprietary textured macro surface on the superior and inferior surfaces provide strong initial bone purchase. Micro and cellular textures on all surfaces support multi-axial new bone growth.


Enable majority of the devices to be placed on the apophyseal ring, the strongest portion of the vertebral endplate, to preserve endplate integrity and reduce the risk of implant subsidence.


Devices utilize less material and feature extremely large windows for excellent postoperative radiographic visualization and fusion evaluation, as well as increased bone graft volume. Furthermore, side windows allow for additional bone growth in the axial plane, unlike traditional interbody devices that only allow for cephalad/caudal bone growth.


Simplified surgical technique. The ENDOSKELETON® line of devices is supported by simple, intuitive instrumentation for easy and consistent implantation. The devices are available in a variety of sizes to accommodate various patient anatomies.


  • Cervical cage with integrated fixation
  • Features two grit-blasted integrated anti-backout or standard screws for immediate mechanical stability
    Integrated collar prevents screw backout
  • Screws act independently from the implant to allow for variable angle screw placement
  • Zero-profile design prevents disruption to adjacent anatomical structures
  • Available in a variety sizes to accommodate various patient anatomies

The Endoskeleton® TCS is indicated for use for anterior cervical interbody fusion in skeletally mature patients with Degenerative Disc Disease (DDD) of the cervical spine at one disc level from C-2 to T-1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have received 6 weeks of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TCS is indicated to be used with autograft bone. The device is a standalone system when used with Endoskeleton® TCS integrated screws, and when used without the integrated screws, it requires additional supplemental fixation cleared in the cervical spine. This implant may be covered by one or more patents and pending patent applications.

Find our more about our products

Get in touch for further information


Move Forward


U4 / 22 Newstead Terrace, Newstead, Queensland 4006

PO Box 7111, East Brisbane, Queensland 4169


T: +61 (0)7 3733 0107
F: +61 (0)7 3257 2086